Humana Inc. (HUM) — Fair Value Analysis

Base-case fair value (P50): $376.85 · Current price: $396.75 · Verdict: Fairly Valued

The Verdict on HUM

Based on our Monte Carlo simulations, Humana (HUM) is currently deemed Fairly Valued. The stock trades at $396.75, while our median fair value (P50) stands at $376.85. This indicates an approximate -5.0% potential upside from its current trading level to our simulated fair value. While this suggests some potential for appreciation, the market is largely reflecting its intrinsic value under a range of forward-looking scenarios. Our analysis accounts for thousands of possible future states to arrive at this statistically robust fair value assessment for HUM, anchoring our perspective that the stock is neither significantly overvalued nor undervalued at this juncture.

How HUM stacks up against Healthcare

Humana’s valuation assessment comes alongside a "weak" quality tier rating when evaluated against the broader Healthcare sector. This weak operational and financial health ranking, derived from our comprehensive proprietary metrics, suggests that while HUM’s $396.75 aligns closely with its $376.85 fair value, there may be underlying challenges or inefficiencies compared to industry peers. Investors should consider this quality tier in conjunction with the fair value assessment, as a weak quality rating could imply higher risk or lower long-term growth potential, even with a modest -5.0% to its median target.

What this means for investors

For investors tracking Humana, the "Fairly Valued" verdict and the -5.0% gap to the $376.85 fair value from $396.75 suggest that current prices are largely reflective of fundamental expectations. The accompanying "weak" quality tier further signals that while there isn't significant undervaluation, the company's operational strength might not be best-in-class within the Healthcare sector. This combination implies that a substantial re-rating may require significant operational improvements. To gain deeper insight into the full Monte Carlo distribution, including the precise bear-case (P10) and bull-case (P90) targets, sign up for a free FairCurve account. This will allow you to track HUM's fair value as new fundamentals are released.